Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
Soranobu Ninomiya(Houston Methodist), Carlos A. Ramos(Methodist Hospital)
Cited by 312
Related Papers
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
|Blood|2014|738
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
|Journal of Clinical Investigation|2017|368
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
|Nature Reviews Clinical Oncology|2022|324
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains
|Journal of Clinical Investigation|2016|280